Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
Adolescent
Adult
Aged
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Chikungunya Fever
/ epidemiology
Chikungunya virus
/ immunology
Child
Child, Preschool
Cross-Sectional Studies
Hospitals
/ statistics & numerical data
Humans
Immunoglobulin G
/ blood
Immunoglobulin M
/ blood
India
/ epidemiology
Infant
Infant, Newborn
Middle Aged
Prevalence
Seroepidemiologic Studies
Young Adult
CHIKV
chikungunya
microneutralization assay
seroprevalence
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
30
03
2019
accepted:
24
08
2019
pubmed:
30
8
2019
medline:
11
3
2021
entrez:
30
8
2019
Statut:
ppublish
Résumé
Chikungunya fever is a viral disease transmitted to humans by the bite of infected mosquitoes. The disease is characterized by fever, headache, rash, severe joint, and muscle pain. To evaluate the disease burden in the population and the effectiveness of public health measures, periodic seroprevalence surveys are essential. Chikungunya outbreaks were reported from many Asian countries since 2005, after more than three decades of disappearance. The study aimed to estimate the seroprevalence of the chikungunya virus in southern parts of Karnataka state, through demonstrating chikungunya virus-specific neutralizing antibodies. A cross-sectional study was carried out using 509 archived blood samples from a hospital-based acute febrile illness surveillance project, representative of the period between June 2014 and 2018. The study reported a 3.7% seroprevalence of chikungunya virus-neutralizing antibodies in Thirthahalli and Hosanagara taluks of South Karnataka. The low prevalence of chikungunya-neutralizing antibodies indicates that a major population is unexposed and prone to future outbreaks.
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-123Subventions
Organisme : ACL HHS
ID : U01GH001051
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.